Mitochondrial myopathy developing on treatment with the HMG CoA reductase inhibitors--simvastatin and pravastatin.

Suppr

超能文献

作者信息

England J D, Walsh J C, Stewart P, Boyd I, Rohan A, Halmagyi G M

出版信息

Aust N Z J Med. 1995 Aug;25(4):374-5. doi: 10.1111/j.1445-5994.1995.tb01912.x.

DOI:10.1111/j.1445-5994.1995.tb01912.x

PMID:8540887

Abstract

摘要

相似文献

Mitochondrial myopathy developing on treatment with the HMG CoA reductase inhibitors--simvastatin and pravastatin.

Aust N Z J Med. 1995 Aug;25(4):374-5. doi: 10.1111/j.1445-5994.1995.tb01912.x.

[Myopathy caused by inhibitors of hydroxymethylglutaryl-coenzyme A reductase].

Rev Neurol. 1997 Jun;25(142):869-71.

Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.HMG-CoA还原酶抑制剂单药治疗原发性高胆固醇血症的安全性和有效性的比较评估。

Ann Pharmacother. 1995 Jul-Aug;29(7-8):743-59. doi: 10.1177/106002809502907-818.

HMG-CoA reductase inhibitor treatment in renal insufficiency.肾功能不全时的HMG-CoA还原酶抑制剂治疗

Nephrol Dial Transplant. 1996 Oct;11(10):1951-2. doi: 10.1093/oxfordjournals.ndt.a027076.

[Porphyria cutanea tarda induced by HMG CoA reductase inhibitors: simvastatin, pravastatin].

Ann Dermatol Venereol. 1994;121(11):817-9.

Generalized eczematous skin rash possibly due to HMG-CoA reductase inhibitors.泛发性湿疹样皮疹可能由HMG-CoA还原酶抑制剂引起。

Dermatology. 1993;186(4):248-52. doi: 10.1159/000247363.

Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.HMG-CoA还原酶抑制剂的药效学与药代动力学。异同点。

Clin Pharmacokinet. 1997 May;32(5):403-25. doi: 10.2165/00003088-199732050-00005.

Pravastatin, simvastatin, and lovastatin for lowering serum cholesterol concentrations.普伐他汀、辛伐他汀和洛伐他汀用于降低血清胆固醇浓度。

Med Lett Drugs Ther. 1992 Jun 12;34(872):57-8.

Potential risk of myopathy by HMG-CoA reductase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibers.HMG-CoA还原酶抑制剂引发肌病的潜在风险：普伐他汀与辛伐他汀对大鼠骨骼肌纤维膜电特性影响的比较

J Pharmacol Exp Ther. 1995 Dec;275(3):1490-6.

[The HMG-CoA reductase inhibitors simvastatin and pravastatin. No indication for side effects in use on humans].

Fortschr Ophthalmol. 1991;88(6):843-5.

引用本文的文献

Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA's Adverse Event Reporting System.与他汀类药物使用相关的肌萎缩侧索硬化症：FDA 不良事件报告系统的比例失调分析。

Drug Saf. 2018 Apr;41(4):403-413. doi: 10.1007/s40264-017-0620-4.

Update on toxic myopathies.中毒性肌病的最新进展。

Curr Neurol Neurosci Rep. 2012 Feb;12(1):54-61. doi: 10.1007/s11910-011-0232-9.

Statin-associated muscle-related adverse effects: a case series of 354 patients.他汀类药物相关肌肉相关不良反应：354 例患者的病例系列。

Pharmacotherapy. 2010 Jun;30(6):541-53. doi: 10.1592/phco.30.6.541.

Amyotrophic lateral sclerosis-like conditions in possible association with cholesterol-lowering drugs: an analysis of patient reports to the University of California, San Diego (UCSD) Statin Effects Study.可能与降胆固醇药物相关的肌萎缩侧索硬化样病症：对向加利福尼亚大学圣地亚哥分校（UCSD）他汀类药物效果研究报告的患者的分析

Drug Saf. 2009;32(8):649-61. doi: 10.2165/00002018-200932080-00004.

High-dose statin use does not impair aerobic capacity or skeletal muscle function in older adults.高剂量他汀类药物的使用不会损害老年人的有氧能力或骨骼肌功能。

Age (Dordr). 2008 Dec;30(4):283-91. doi: 10.1007/s11357-008-9070-3. Epub 2008 Aug 21.

Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.他汀类药物的不良反应：文献综述及线粒体机制证据

Am J Cardiovasc Drugs. 2008;8(6):373-418. doi: 10.2165/0129784-200808060-00004.

Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry.加州大学圣地亚哥分校他汀类药物研究的概念基础：一项评估他汀类药物对认知、行为和生物化学影响的随机对照试验。

Arch Intern Med. 2004 Jan 26;164(2):153-62. doi: 10.1001/archinte.164.2.153.

How well tolerated are lipid-lowering drugs?降脂药物的耐受性如何？

Drugs Aging. 2001;18(9):665-83. doi: 10.2165/00002512-200118090-00003.

Rheumatic manifestations of current pharmacopeia.现行药典中的风湿性表现。

Curr Rheumatol Rep. 2000 Apr;2(2):151-5. doi: 10.1007/s11926-000-0055-1.

HMG-CoA reductase inhibitors and myotoxicity.HMG-CoA还原酶抑制剂与肌毒性。

Drug Saf. 2000 Jun;22(6):441-57. doi: 10.2165/00002018-200022060-00003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验